Cardiac Electrophysiology · Conduction System Pacing
How do LBBAP capture thresholds behave over 10–15 years?
Key takeaways
- No genuine 10–15 year clinical dataset exists yet — LBBAP was first described in 2017, so the longest published follow-up reaches only about 2–5 years.
- Within that window, LBB capture thresholds are remarkably flat, staying near 0.6–0.9 V at 0.4–0.5 ms with minimal drift and outperforming His-bundle pacing.
- The important long-term question is usually not a rising voltage but a change in what is being captured — gradual loss of direct conduction-system capture.
- Projections to a decade lean on 3830 lead engineering data: roughly 97% ventricular lead survival at 10 years in conventional positions.
- Decade-long surveillance must trend paced QRS morphology and capture type, not the threshold number alone.
1. Start with an honest caveat about the data horizon
Left bundle branch area pacing (LBBAP) is a young technique. It was first reported in 2017, which means that even the earliest treated patients have only about eight to nine years of follow-up, and the large, carefully phenotyped series published to date extend only to roughly two to five years. A precise, evidence-grounded description of LBBAP thresholds at ten to fifteen years therefore does not yet exist as direct clinical data.
Any answer covering that horizon is a projection, assembled from three sources: the medium-term threshold data that does exist, the engineering and reliability record of the lead most commonly used for LBBAP, and the known biological mechanisms that move pacing thresholds over the life of any lead. Keeping those three strands separate is what makes a long-range answer trustworthy rather than speculative.
2. What the medium-term evidence actually shows
The reassuring headline is that, over the intervals we can measure, LBB capture thresholds are strikingly stable. In a large single-center prospective cohort of more than six hundred patients, the unipolar LBB capture threshold was essentially unchanged from implant to two years — starting near 0.65 V and finishing near 0.69 V at 0.5 ms. Sensed R-wave amplitude rose slightly in the first month and then held steady, and impedance fell quickly over the first weeks before plateauing, exactly the maturation pattern expected of a well-seated, steroid-eluting lead.
The contrast with His-bundle pacing is instructive. His-bundle thresholds tend to start higher and climb meaningfully over follow-up, whereas LBBAP thresholds stay low and mostly flat. That difference — lower, more stable, and requiring fewer revisions — is a large part of why LBBAP has largely displaced His-bundle pacing as the preferred conduction-system target.
3. The real long-term story: threshold value vs. type of capture
Here is the point most easily missed. When people ask how LBBAP thresholds "behave" over many years, they usually picture a single voltage number slowly creeping upward. In LBBAP the more clinically relevant change is different and subtler: a shift in what the lead is actually capturing.
An LBBAP lead can capture the left bundle directly (selective or non-selective) or capture only the adjacent left-ventricular septal myocardium. Over time some patients drift from true conduction-system capture toward myocardial-only capture. Loss of conduction-system capture has been reported in roughly four to five percent of patients within about nineteen months, and the crucial catch is that the ordinary threshold and impedance readings can still look perfectly acceptable while this is happening. A lead that has micro-perforated or progressed slightly within the septum may pace with a normal-looking output yet no longer engage the bundle.
So a lead can maintain an excellent-looking capture threshold for a decade and still deliver progressively less physiological pacing. That is why the number on the follow-up printout is only half of the surveillance question.
4. Mechanisms that could move thresholds across a decade
- Fibrotic maturation. Every lead forms a fibrous capsule at the electrode–tissue interface. In older leads this drove the classic early threshold "peak." Steroid elution blunts that response and is a major reason LBBAP thresholds settle low and stay there.
- Micro-dislodgement and septal progression. Because the helix sits deep in the interventricular septum and endures continuous contraction, forward creep or micro-perforation is possible. This can degrade conduction-system capture — sometimes with an intact-looking bipolar threshold but a changed unipolar behavior.
- Reverse remodeling. In patients whose cardiomyopathy improves with physiological pacing, the underlying myocardial substrate changes over months to years, which can subtly alter capture characteristics.
- Anodal and bipolar effects. The ring electrode captures septal myocardium and can contribute anodal capture at higher outputs, which is why unipolar and bipolar behavior should be interpreted together rather than as a single figure.
- Very late conductor and insulation aging. Any lead in the body for ten to fifteen years faces mechanical fatigue. This is where lead engineering data, rather than clinical threshold trends, carries most of the weight.
5. Lead durability: the engineering basis for a 10–15 year projection
Most LBBAP is performed with a single lumenless, fixed-helix, steroid-eluting lead that has a long track record in other positions. Real-world reliability data for that lead show roughly ninety-seven percent ventricular lead survival at ten years in conventional placements, and manufacturer bench modeling for the left-bundle position projects a fracture-free rate close to complete at ten years. Early large registries report essentially no conduction-system-related fractures over the first few years across thousands of patients.
These figures are genuinely reassuring, but they carry a caveat: the deep-septal LBBAP position is mechanically different from the atrial or apical positions where the ten-year clinical survival data were gathered. The engineering picture supports optimism about the physical lead surviving a decade or more; it does not by itself guarantee that conduction-system capture will still be intact at that point.
6. What decade-long surveillance should actually track
Given all of the above, thoughtful long-term monitoring looks beyond a single voltage:
- Paced QRS morphology over time — including markers such as the V6 R-wave peak time and the right-bundle-block pattern in V1 that signal ongoing left-bundle engagement.
- Unipolar and bipolar behavior side by side, since a discrepancy can reveal micro-perforation before the threshold number moves.
- Output-dependent morphology transitions, which flag a shift between selective, non-selective, and myocardial-only capture.
- Serial trending rather than single snapshots, so a slow drift is visible against the patient's own baseline.
- Battery-longevity projection, because a stable low threshold allows conservative output programming and preserves device life across the horizon in question.
7. Bottom line
Based on the best available medium-term evidence and the durability record of the lead most often used, the reasonable expectation is that LBBAP capture thresholds stay low and stable across many years — flatter and more forgiving than His-bundle pacing. The genuine long-term uncertainty is not a slow voltage climb but whether direct conduction-system capture remains intact. Confident, precise statements specifically at the ten-to-fifteen-year mark will require cohorts that simply have not aged that far yet. Until they do, the practical answer is to expect stability, plan surveillance around capture type rather than voltage alone, and treat any long-range figure as a well-reasoned projection.